Jamie Clark
Stock Analyst at Rothschild & Co
(2.65)
# 2,012
Out of 5,112 analysts
9
Total ratings
85.71%
Success rate
13.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $268.66 | +15.76% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $560.21 | -15.39% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $178.70 | +32.06% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $193.85 | -6.11% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $252.03 | +9.51% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $176.15 | +10.70% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $222.52 | +24.03% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $268.66
Upside: +15.76%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $560.21
Upside: -15.39%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $178.70
Upside: +32.06%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $193.85
Upside: -6.11%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $252.03
Upside: +9.51%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $176.15
Upside: +10.70%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $222.52
Upside: +24.03%